P. Becherini

发表

SIRT6 deacetylase activity regulates NAMPT activity and NAD(P)(H) pools in cancer cells

P. Damonte, L. Sturla, S. Bruzzone, 2018, The FASEB Journal.

Clinical Cancer esearch cer Therapy : Preclinical or Regression and Curability of Preclinical Neuroblastoma els by PEGylated SN 38 ( EZN-2208 ) , a Novel R oisomerase I Inhibitor

M. Cilli, L. Greenberger, M. Ponzoni, 2010 .

Tumor Regression and Curability of Preclinical Neuroblastoma Models by PEGylated SN38 (EZN-2208), a Novel Topoisomerase I Inhibitor

D. Ribatti, M. Cilli, L. Greenberger, 2010, Clinical Cancer Research.

SIRT6 inhibitors with salicylate-like structure show immunosuppressive and chemosensitizing effects.

G. Damonte, P. Damonte, S. Bruzzone, 2017, Bioorganic & medicinal chemistry.

Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings.

M. Cilli, W. Arap, R. Longhi, 2013, Journal of controlled release : official journal of the Controlled Release Society.

Transcriptome analysis defines myocardium gene signatures in children with ToF and ASD and reveals disease-specific molecular reprogramming in response to surgery with cardiopulmonary bypass

M. L. Belli, D. Cangelosi, A. Eva, 2020, Journal of Translational Medicine.

sTRAIL coupled to liposomes improves its pharmacokinetic profile and overcomes neuroblastoma tumour resistance in combination with Bortezomib.

M. Cilli, F. Pastorino, C. Brignole, 2014, Journal of controlled release : official journal of the Controlled Release Society.

Fasting-mimicking diet and hormone therapy induce breast cancer regression

A. Ballestrero, H. Clevers, M. Cilli, 2020, Nature.

Safety and Feasibility of Fasting-Mimicking Diet and Effects on Nutritional Status and Circulating Metabolic and Inflammatory Factors in Cancer Patients Undergoing Active Treatment

V. Longo, S. Sukkar, F. Montecucco, 2021, Cancers.

Nicotinic Acid Phosphoribosyltransferase Regulates Cancer Cell Metabolism, Susceptibility to NAMPT Inhibitors, and DNA Repair.

A. Ballestrero, S. Bruzzone, S. Ravera, 2017, Cancer research.

Use of Attribute Driven Incremental Discretization and Logic Learning Machine to build a prognostic classifier for neuroblastoma patients

Marco Muselli, Stefano Parodi, Rogier Versteeg, 2014, BMC Bioinformatics.

Mesenchymal Stem Cell‐Derived Extracellular Vesicles as Mediators of Anti‐Inflammatory Effects: Endorsement of Macrophage Polarization

R. Cancedda, M. Pozzobon, Roberta Tasso, 2017, Stem cells translational medicine.

Liposome-mediated therapy of neuroblastoma.

C. Tacchetti, R. Longhi, A. Corti, 2009, Methods in enzymology.

Abstract 5609: Bortezomib enhanced cytotoxic effects of novel sTRAIL-targeted nanocarriers against neuroectodermal tumors .

Fabio Pastorino, Pamela Becherini, F. Pastorino, 2013 .

Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma.

D. Ribatti, B. Nico, M. Cilli, 2010, Journal of controlled release : official journal of the Controlled Release Society.

First Characterization of Human Amniotic Fluid Stem Cell Extracellular Vesicles as a Powerful Paracrine Tool Endowed with Regenerative Potential

R. Cancedda, M. Pozzobon, T. Bandiera, 2017, Stem cells translational medicine.

The use of the orthotopic model to validate antivascular therapies for cancer.

D. Ribatti, M. Cilli, F. Pastorino, 2011, The International journal of developmental biology.

CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents

A. Neri, A. De Flora, S. Bruzzone, 2023, Antioxidants.

SIRT6 enhances oxidative phosphorylation in breast cancer and promotes mammary tumorigenesis in mice

P. Damonte, S. Bruzzone, S. Ravera, 2021, Cancer & metabolism.

Amino acid depletion triggered by ʟ-asparaginase sensitizes MM cells to carfilzomib by inducing mitochondria ROS-mediated cell death.

M. Zucchetti, A. Neri, S. Bruzzone, 2020, Blood advances.

Recent advances in targeted anti-vasculature therapy: the neuroblastoma model.

D. Ribatti, T. Allen, F. Pastorino, 2009, Current drug targets.

Targeting the deacetylase SIRT6 unveils spliceosome deregulation as exploitable vulnerability for aggressive myeloma

A. Neri, S. Bruzzone, A. Nencioni, 2023, Blood Advances.

Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatment

N. Munshi, M. Samur, A. Neri, 2021, Haematologica.

Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings.

M. Cilli, W. Arap, R. Longhi, 2013, Journal of controlled release : official journal of the Controlled Release Society.

Cyclic fasting bolsters cholesterol biosynthesis inhibitors’ anticancer activity

M. Adorni, A. Nencioni, I. Caffa, 2023, Nature communications.